Tango Therapeutics, Inc. TNGX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-09-03
Chart by TradingView
3/9
Piotroski F — financial health
5.58
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Valuation · market cap as of 2026-06-29
Market cap$5.1B
P / S82.1×
P / B14.8×
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $62.4M | $42.1M | $36.5M | $24.9M | $37.0M |
| Operating income | -$111.3M | -$145.6M | -$114.2M | -$111.1M | -$58.2M |
| Net income | -$101.6M | -$130.3M | -$101.7M | -$108.2M | -$58.2M |
| Operating cash flow | -$138.9M | -$131.5M | -$118.0M | -$109.1M | -$59.5M |
| Free cash flow | -$139.9M | -$132.3M | -$119.5M | -$116.8M | -$61.4M |
| Total assets | $398.7M | $316.5M | $402.6M | $436.5M | $500.2M |
| Total liabilities | $52.5M | $117.0M | $149.5M | $187.0M | $155.4M |
| Shareholders' equity | $346.2M | $199.5M | $253.1M | $249.5M | $344.7M |
| Ratios | |||||
| Operating margin | -178.4% | -346.1% | -312.6% | -446.8% | -157.1% |
| Net margin | -162.9% | -309.7% | -278.5% | -435.1% | -157.2% |
| FCF margin | -224.3% | -314.4% | -327.2% | -469.7% | -165.7% |
| Return on assets | -25.5% | -41.2% | -25.3% | -24.8% | -11.6% |
| Return on equity | -29.3% | -65.3% | -40.2% | -43.4% | -16.9% |
| Current ratio | 16.32 | 6.98 | 7.54 | 6.76 | 12.10 |
| Revenue growth | 48.3% | 15.2% | 46.9% | -32.9% | 383.8% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 533,937 | $11.2M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 5.58 (safe)
- Working capital / assets 0.833
- Retained earnings / assets -1.513
- EBIT / assets -0.279
- Equity / liabilities 6.593
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001819133 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.